Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

January 13, 2022

The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective.

Journal of Pharmaceutical Policy and Practice
Izzati-Nadhirah MohamadHong-Bee Ker
January 13, 2022

Klebsiella-induced infections in domestic species: a case-series study in 697 animals (1997-2019).

Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]
Márcio Garcia RibeiroAntonio Carlos Paes
January 12, 2022

Administration of Systemic Antibiotics for Dental Treatment in Kosovo Major Dental Clinics: A National Survey.

European Journal of Dentistry
Lirim MustafaIvana Sutej
January 11, 2022

Empiric antimicrobial therapy for early-onset pneumonia in severe trauma patients.

European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
Maël GennequinArnaud Foucrier
January 11, 2022

In vitro activity of cefepime-taniborbactam against carbapenemase producing Enterobacterales and Pseudomonas aeruginosa isolates recovered in Spain.

Antimicrobial Agents and Chemotherapy
Marta Hernández-GarcíaRafael Cantón
January 8, 2022

Acute localized exanthematous pustulosis because of cefixime in a child: case report and review of pediatric cases.

International Journal of Dermatology
Atiye AkbayrakOmer Kutlu
January 7, 2022

A Case of Successful Endovascular Aortic Repair of Primary Aortoenteric Fistula Without Aortic Explantation.

Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists
Joshua WinstonThodur Vasudevan
January 7, 2022

Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Gabriele ArcariAlessandra Carattoli
January 7, 2022

Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa.

International Journal of Antimicrobial Agents
Laura CorbellaJosé María Aguado
January 6, 2022
Case Report
Open Access

A discrepant presentation of bacteremia in the emergency department linked to a Fusobacterium nucleatum infection: a case report.

Journal of Medical Case Reports
Johnny MichelVirginie Eve Lvovschi

Sign up to follow this feed and discover related papers.

Related Feeds


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2022 Meta ULC. All rights reserved